Gland Pharma Bags USFDA Approval for Angiotensin II 💉 — 180 Days of Monopoly Begins!
Date of Publishing -
🟢 At a Glance Gland Pharma just got USFDA approval for Angiotensin II Acetate Injection (2.5 mg/mL) — a drug used to raise blood pressure in patients with septic shock. Why is this a big deal? Because Gland is the first-to-file, which means they get 180 days of generic exclusivity in the US market. The original drug did $58 million in sales over the past year. Ka-ching! 💰
💊 The Drug, The Market, The Moat
Product
Brand Equivalent
US Sales (12M Ending Mar ’25)
Exclusivity
Angiotensin II Acetate Injection
GIAPREZA
$58 million
180 days (solo)
📍 Therapeutic Use: Raises BP in septic/distributive shock
